Arranon Injection
Product Images NDC 66758-165

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Arranon (NDC 66758-165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula For Nelarabine Is 2-amino-9-b-d-arabinofuranosyl-6-methoxy-9h-purine. It Has The Molecular Formula C11h15n5o5 And A Molecular Weight Of 297.27. (Arranon 01)

Chemical structure of nelarabine, the active ingredient in Arranon. The structure depicts the molecular arrangement of atoms and bonds characteristic of nelarabine.*

FDA Label Image

Cartonimage (Carton)

Packaging label for Arranon (nelarabine) Injection 250 mg/50 mL (5 mg/mL) for intravenous infusion. The label indicates a single-dose vial with instructions to discard unused portions. Manufactured by Fareva Unterach GmbH for Sandoz Inc. The label includes storage and usage details, barcode, and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.